Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)

Affiliations

• ¹ Royal Melbourne Hospital, Parkville, Victoria, Australia. Electronic address: [email protected].
• ² Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia.
• ³ Royal Melbourne Hospital, Parkville, Victoria, Australia; Melbourne EpiCentre, University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
• ⁴ Royal Melbourne Hospital, Parkville, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
• ⁵ Royal Melbourne Hospital, Parkville, Victoria, Australia.
• ⁶ Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
• ⁷ Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
• ⁸ Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, Victoria, Australia.
• ⁹ Royal Melbourne Hospital, Parkville, Victoria, Australia; Walter and Eliza Hall Institute, Melbourne, Victoria, Australia; Melbourne EpiCentre, University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.